Medtronic: Referral-Building Talks, Marketing Plans and Tickets

Medtronic agreed to pay $9.9 million in its 2014 kickback settlement to resolve allegations that paid talks, free marketing plans and sporting-event tickets induced physicians to implant its pacemakers and defibrillators. The alleged purpose was to keep physicians using Medtronic products or persuade them to switch from a competitor. A former employee’s complaint went inside that sales relationship, describing dinner speakers who barely spoke and invitations that depended on continued implant business.

The Justice Department announced the settlement of this California healthcare fraud case on May 28, 2014. It alleged that Medtronic caused false claims to Medicare and Medicaid by rewarding the physicians who chose its devices. The speaking events, the government alleged, were intended to increase referral business for the implanting physicians, while the marketing and business-development plans came at no cost to them. The manufacturer was allegedly helping build the practices that could send device business back to it.

Why the Implanting Physician Mattered

This is why the benefits alleged in Medtronic’s case mattered commercially. A referral-building event could bring patients to the physician who used the company’s implants. Free business-development work could benefit that physician’s practice. Tickets supplied a personal benefit. Each alleged benefit reached someone who could influence whether Medtronic retained or won the implant business.

Patients depended on the physician’s medical judgment, taxpayers funded the care, and competing manufacturers had to win the same business without the alleged rewards.

Paid Talks With Little Talking

The whistleblower alleged that Medtronic paid physicians $1,000 or more for dinner events even when they had no real speaking responsibility. According to the complaint, the company supplied prepared slides so the physicians did not have to prepare a presentation. Then came the account of what the supposed speaker actually did:

On that account, a physician could receive a speaking fee without giving a talk. The allegation puts the value of the relationship ahead of the value of the presentation.

The complaint also described how Medtronic allegedly managed that relationship after the dinner. According to the complaint, sales representatives told physicians that invitations to lavish dinners and resort weekends depended on remaining high-volume implanters and continuing to use Medtronic devices. Marketing and sales personnel allegedly tracked physicians who stopped using the company’s implants each quarter and sometimes removed them from invitation lists.

That detail gives a sales or marketing insider something concrete to recognize: the same physician’s product use and access to hospitality appearing in the company’s decisions. The complaint alleged a continuing exchange, with future invitations tied to future implant business.

Free Marketing Plans and the Expected Return

Free marketing and business-development plans were part of the government’s kickback allegation because they offered value to physicians whose device choices could benefit Medtronic. The alleged return was continued business or business taken from a competitor.

The complaint made the expected return unusually specific. It alleged that Medtronic sponsored lunches or dinners expecting between two and six patients to be referred for its implants in the third quarter. That is a sales target expressed in patients. Read beside the allegation about invitation lists, it describes a business tracking what it expected to get back from its hospitality.

A 2020 forensic accounting review in the Journal of Forensic and Investigative Accounting explains that kickbacks can involve indirect and noncash compensation, including economic relationships more complex than a simple payment for services.

For this case, the useful point is the value of work done for the physician’s business. The government put free marketing plans beside cash speaking payments and tickets in the same allegation. Practice-building help could serve the same sales objective as money paid directly to a physician.

The pattern also appears in the separate case against Cardiovascular Systems, which agreed to pay $8 million in 2016. The government alleged that it developed marketing materials promoting physicians who used its devices, coordinated meetings with referring physicians, and developed business-expansion plans for device users. Both cases put the manufacturer’s work for a physician’s practice at the center of the alleged inducement. The benefit could arrive as new business for the customer.

The Separate Medtronic Study and Registry Settlement

Medtronic’s 2011 kickback settlement concerned alleged payments through post-market studies and device registries to induce pacemaker and defibrillator implantation. It resolved two other whistleblower lawsuits.

The product families were the same, but the alleged payment arrangements were different. The earlier case concerned study and registry payments.

How Much Is a Whistleblower Claim Worth?

The Justice Department announced an approximately $1.73 million whistleblower reward from the settlement for the former Medtronic employee who brought this case. The employee’s qui tam complaint started the case under the False Claims Act.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

For someone inside device sales, marketing or a physician’s practice, the connection may be visible in work they already know: the event, the development plan, the expected referrals or the decisions about future invitations.

You Know What the Benefits Were Buying

If you know how physician benefits drove implant sales, speak to our whistleblower experts about building your medical device fraud case. We build the case with you and bring in medical device whistleblower lawyers who understand physician inducements and Medicare and Medicaid claims. We stay beside you as your knowledge of the business becomes the foundation of the case.